Colorectal Cancer Screening

Screening and surveillance for early detection of colorectal cancer in New Zealand.

Screening for colorectal cancer is available for all New Zealand citizens using a stool sample between the age of 58-75. For people at increased risk of cancer colonoscopy is a more sensitive examination for the detection of cancer or detection and treatment of precancerous polyps.

You can assess the risk of a patient based on their family history. The complete national guidelines are available here

Family History and Risk Assessment

  • Who is in this group

    • One first-degree relative diagnosed with colorectal cancer at ≥55 years.

    Recommendations

    • No routine colonoscopy surveillance required.

    • Strongly advise participation in the National Bowel Screening Programme (NBSP) when eligible.

    • Encourage healthy lifestyle choices and prompt reporting of bowel symptoms.

    GP takeaway

    Manage through NBSP, not colonoscopy.

  • Who is in this group

    • One first-degree relative with colorectal cancer <55 years, OR

    • Two first-degree relatives on the same side of the family/whānau with colorectal cancer at any age
      (and no Category 3 high-risk features).

    Surveillance recommendations

    • Colonoscopy every 5 years, starting at:

      • Age 50, OR

      • 10 years younger than the youngest affected relative
        (whichever comes first).

    • If a high-quality colonoscopy has been performed within the last 5 years:

      • From age 60, the individual may also participate in NBSP.

    • If polyps are found requiring ongoing surveillance:

      • Continue colonoscopy per Polyp Surveillance Guidelines (2020).

    • When colonoscopy surveillance is no longer indicated, return to NBSP.

    Important equity note

    • For Māori and Pacific peoples:

      • Continue colonoscopic surveillance until age 60

      • Do not switch to NBSP at 50, despite earlier NBSP eligibility.

    GP takeaway

    This is a structured colonoscopy programme, FIT testing alone is not sufficient before age 60.

  • Who is in this group (any one of the following)

    • Known or suspected Lynch syndrome, FAP, or other familial CRC syndromes

    • One first-degree + ≥2 first/second-degree relatives (same side) with CRC

    • Two first-degree, or one first-degree + ≥1 second-degree relative with CRC plus:

      • Diagnosis ≤54 years, or

      • Multiple CRCs, or

      • Lynch-associated extracolonic cancer (eg endometrial, ovarian)

    • CRC in a first-degree relative <50 years with tumour IHC suggesting Lynch

    • CRC associated with multiple adenomas / polyposis

    • First-degree relative with multiple colonic polyps meeting polyposis thresholds

    Recommendations

    • Refer to the New Zealand Familial GI Cancer Service (NZFGCS) or a genetic service.

    • Follow the individualised colonoscopy surveillance plan advised by specialists.

    GP takeaway

    Do not manage independently, A colorectal cancer specialist can advise on a plan acknowledging a genetics-led risk stratification is often required.